The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E
Open accessAbstract
Toll-like receptors (TLRs) and the downstream adaptor molecule myeloid differentiation factor 88 (MyD88) play an essential role in the innate immune responses. Here, we demonstrate that genetic deficiency of TLR4 or MyD88 is associated with a significant reduction of aortic plaque areas in atherosclerosis-prone apolipoprotein E-deficient mice, despite persistent hypercholesterolemia, implying an important role for the innate immune system in atherogenesis. Apolipoprotein E-deficient mice that also lacked TLR4 or MyD88 demonstrated reduced aortic atherosclerosis that was associated with reductions in circulating levels of proinflammatory cytokines IL-12 or monocyte chemoattractant protein 1, plaque lipid content, numbers of macrophage, and cyclooxygenase 2 immunoreactivity in their plaques. Endothelial-leukocyte adhesion in response to minimally modified low-density lipoprotein was reduced in aortic endothelial cells derived from MyD88-deficient mice. Taken together, our results suggest an important role for TLR4 and MyD88 signaling in atherosclerosis in a hypercholesterolemic mouse model, providing a pathophysiologic link between innate immunity, inflammation, and atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deficiency in either TLR2 or TLR4 signalling also reduced atherosclerotic disease in mouse models35–37, and TLR4, specifically, has been shown to mediate inflammatory responses to free fatty acids,”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [36]
In the citing paper
“TLR signalling is also implicated in the pathogenesis of atherosclerotic disease35–37.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [36]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein
Wright, S. D., Ramos, R., Tobias, P. S., Ulevitch, R. J., & Mathison, J. C. (1990) · Science · doi:10.1126/science.1698311 · Cited by 3,986
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574
Flagged first, then by citations
Research works printed but not linked: 1
- Ameziane, N., Beillat, T., Verpillat, P., Chollet-Martin, S., Aumont, M. C., Seknadji, P., Lamotte, M., Lebret, D., Ollivier, V. & De Prost, D. (2003) Arterioscler. Thromb. Vasc. Biol. 23, 61–64.
Cited by
Sorted by citations
Items 501–600 of 1,000
Chmielewski, S., Piaszyk-Borychowska, A., Wesoły, J., & Bluyssen, H. A. R. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1087519 · Cited by 43
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case–control study
Galluzzo, S., Patti, G., Dicuonzo, G., Sciascio, G. D., Tonini, G., Ferraro, E., Spoto, C., Campanale, R. E., Zoccoli, A., & Angeletti, S. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.04.005 · Cited by 43
Du, B., Luo, W., Li, R., Tan, B., Han, H., Lü, X., Li, D., Qian, M., Zhang, D., Zhao, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455535 · Cited by 43
The role of the inflammasome in cardiovascular diseases
Li, X., Deroide, N., & Mallat, Z. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1144-3 · Cited by 43
Menghini, R., Campia, U., Tesauro, M., Marino, A., Rovella, V., Rodia, G., Schinzari, F., Tolusso, B., Daniele, N. D., Federici, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099053 · Cited by 42
Huang, C., Sheu, W. H., & Chiang, A. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400687 · Cited by 42
Activation of an Innate Immune Receptor, Nod1, Accelerates Atherogenesis in Apoe−/− Mice
Kanno, S., Nishio, H., Tanaka, T., Motomura, Y., Murata, K., Ihara, K., Onimaru, M., Yamasaki, S., Kono, H., Sueishi, K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302841 · Cited by 42
The activation of liver X receptors inhibits toll‐like receptor‐9‐induced foam cell formation
Sorrentino, R., Morello, S., Chen, S., Bonavita, E., & Pinto, A. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22022 · Cited by 42
The emerging role of galectins in cardiovascular disease
van der Hoeven, N. W., Hollander, M. R., Yıldırım, C., Jansen, M. F., Teunissen, P. F. A., Horrevoets, A. J. G., Kraan, T. C. T. M. V. D. P., & van Royen, N. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.02.006 · Cited by 42
Chukkapalli, S. S., Velsko, I. M., Rivera‐Kweh, M. F., Larjava, H., Lucas, A., & Kesavalu, L. N. (2016) · Molecular Oral Microbiology · doi:10.1111/omi.12165 · Cited by 42
Zhu, L., Gong, X., Jianping, G., Xuan, Y., Fu, T., Ni, S., Xu, L., & Ji, N. (2020) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20209346 · Cited by 42
RetractedGenetic ablation of IRAK4 kinase activity inhibits vascular lesion formation
Rekhter, M. D., Staschke, K. A., Estridge, T. B., Rutherford, P., Jackson, N. K., Gifford‐Moore, D. S., FOXWORTHY, P. S., Reidy, C. A., Huang, X.-D., Kalbfleisch, M. J., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.12.186 · Cited by 42
Endothelial Lipase is Increased by Inflammation and Promotes LDL Uptake in Macrophages
Yasuda, T., Hirata, K., Ishida, T., Kojima, Y., Tanaka, H., Okada, T., Quertermous, T., & Yokoyama, M. (2007) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e502 · Cited by 43
van Keulen, J. K., de Kleijn, D. P. V., Nijhuis, M. M. O., Busser, E., Velema, E., Fijnheer, R., van der Graaf, Y., Moll, F. L., de Vries, J. P., & Pasterkamp, G. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.014 · Cited by 42
Regulation of TLR4 Expression Is a Tale About Tail
Yan, Z.-Q. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000250933.92917.dd · Cited by 42
Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis
Rodríguez‐Rodríguez, L., López‐Mejías, R., García-Bermúdez, M., González‐Juanatey, C., González-Gay, M. Á., & Martin, J. J. (2012) · Mediators of Inflammation · doi:10.1155/2012/574817 · Cited by 42
Gu, J., Wang, D.-F., Yan, X.-G., Zhong, W.-L., Zhang, J., Fan, B., & Ikuyama, S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00159.2010 · Cited by 41
Pols, T. W. H., Bonta, P. I., Pires, N. M., Rubio, I. O., Vos, M., de Vries, M. R., van Eijk, M., Roelofsen, J., Havekes, L. M., Quax, P. H. A., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.205674 · Cited by 42
Pycnogenol attenuates atherosclerosis by regulating lipid metabolism through the TLR4–NF-κB pathway
Luo, H., Wang, J., Qiao, C., Ma, N., Liu, D., & Zhang, W. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.74 · Cited by 41
Self-citationAntibiotic Treatment Protocols and Germ-Free Mouse Models in Vascular Research
Bayer, F., Ascher, S., Pontarollo, G., & Reinhardt, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02174 · Cited by 44
Nuclear receptors in macrophages: A link between metabolism and inflammation
Szántó, A., & Rőszer, T. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.020 · Cited by 42
Ishibashi, M., Sayers, S., D'Armiento, J. M., Tall, A. R., & Welch, C. L. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.035 · Cited by 41
Toll-like receptor signaling and atherosclerosis
Michelsen, K. S., & Arditi, M. (2006) · Current Opinion in Hematology · doi:10.1097/01.moh.0000219662.88409.7c · Cited by 42
Self-citationGut Microbiota-Derived Metabolites in Atherosclerosis: Pathways, Biomarkers, and Targets
Tonch-Cerbu, A.-K., Boicean, A., Stoia, O., & Teodoru, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178488 · Cited by 46
Ma, C., Ouyang, Q., Huang, Z., Chen, X., Lin, Y., Hu, W., & Lin, L. (2015) · Disease Markers · doi:10.1155/2015/909572 · Cited by 40
Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease
Nilsson, J., Fredrikson, G. N., Björkbacka, H., Chyu, K., & Shah, P. K. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02150.x · Cited by 40
Self-citationAplin, A. C., Ligresti, G., Fogel, E., Zorzi, P., Smith, K. D., & Nicosia, R. F. (2013) · Angiogenesis · doi:10.1007/s10456-013-9384-3 · Cited by 41
Treating atherosclerosis: the potential of Toll-like receptors as therapeutic targets
Cole, J. E., Mitra, A. T., & Monaco, C. G. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.149 · Cited by 40
iPLA2β and its role in male fertility, neurological disorders, metabolic disorders, and inflammation
TURK, J. W., White, T. D., Nelson, A. J., Lei, X., & Ramanadham, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.10.010 · Cited by 40
Lubos, E., Mahoney, C. E., Leopold, J. A., Zhang, Y., Loscalzo, J., & Handy, D. E. (2010) · The FASEB Journal · doi:10.1096/fj.09-147421 · Cited by 40
Ward, J. R., Wilson, H. L., Francis, S., Crossman, D. C., & Sabroe, I. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.03886.x · Cited by 40
TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target
Liu, Y., Yu, H., Zhang, Y., & Zhao, Y. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.05.030 · Cited by 40
Richards, M. R., Black, A. S., Bonnet, D. J., Barish, G. D., Woo, C. W., Tabas, I. A., Curtiss, L. K., & Tobias, P. S. (2012) · Innate Immunity · doi:10.1177/1753425912447130 · Cited by 39
Kramer, C. D., Simas, A. M., He, X., Ingalls, R. R., Weinberg, E. O., & Genco, C. A. (2017) · Anaerobe · doi:10.1016/j.anaerobe.2017.04.011 · Cited by 39
Contribution of the commensal microbiota to atherosclerosis and arterial thrombosis
Kiouptsi, K., & Reinhardt, C. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14483 · Cited by 39
Shelton, C. D., & Byndloss, M. X. (2020) · Infection and Immunity · doi:10.1128/iai.00939-19 · Cited by 43
Shao, L., Zhang, P., Zhang, Y., Lu, Q., & Ma, A. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0421-3 · Cited by 39
Role of Toll like receptor signaling pathway in ischemic coronary artery disease
Satoh, M. (2008) · Frontiers in bioscience · doi:10.2741/3183 · Cited by 39
Hayakawa, S., Tamura, A., Nikiforov, N. G., Koike, H., Kudo, F., Cheng, Y., Miyazaki, T., Kubekina, M. V., Kirichenko, T. V., Orekhov, A. N., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.138539 · Cited by 42
Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis
Loppnow, H., Buerke, M., Werdan, K., & Rose‐John, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01245.x · Cited by 39
Chen, Z. B., Martin, M., Zhao, L., & Shyy, J. Y.-J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000107 · Cited by 40
Yang, L., & Gao, C. (2019) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.3.298 · Cited by 38
RetractedVlacil, A.-K., Schuett, J., Ruppert, V., Soufi, M., Oberoi, R., Shahin, K., Waechter, C., Tschernig, T., Yu, L., Fan, L., et al. (2020) · Basic Research in Cardiology · doi:10.1007/s00395-020-0806-2 · Cited by 38
Carratelli, C. R., Mazzola, N., Paolillo, R., Sorrentino, S., & Rizzo, A. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00586.x · Cited by 38
Schnittker, D. L. K., Kwofie, K., Ashkar, A. A., Trigatti, B. L., & Richards, C. D. (2013) · Mediators of Inflammation · doi:10.1155/2013/317503 · Cited by 37
Toll-like Receptors and Atherosclerosis: Oxidized Ldl As an Endogenous Toll-like Receptor Ligand
Miller, Y. I. (2005) · Future Cardiology · doi:10.2217/14796678.1.6.785 · Cited by 38
Vozenilek, A. E., Navratil, A. R., Green, J. M., Coleman, D. T., Blackburn, C. M. R., Finney, A. C., Pearson, B. H., Chrast, R., Finck, B. N., Klein, R. L., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310455 · Cited by 37
Iacano, A. J., Lewis, H., Hazen, J. E., Andro, H., Smith, J. D., & Gulshan, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-47610-w · Cited by 38
Feng, X., Zhang, Y., Xu, R., Xie, X., Tao, L., Gao, H., Gao, Y., He, Z., & Wang, H. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.035 · Cited by 37
Yan, H., Ma, Y., Li, Y., Zheng, X., Lv, P., Zhang, Y., Li, J., Ma, M., Zhang, L., Li, C., et al. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.12.003 · Cited by 37
Toll‐Like Receptor (TLR)4 and MyD88 are Essential for Atheroprotection by Peritoneal B1a B Cells
Hosseini, H., Li, Y., Kanellakis, P., Tay, C., Cao, A. H., Liu, E., Peter, K., Tipping, P. G., Toh, B., Bobik, A., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002947 · Cited by 37
Gillespie, M. A. K., Gold, E. S., Ramsey, S. A., Podolsky, I., Aderem, A. A., & Ranish, J. A. (2015) · The EMBO Journal · doi:10.15252/embj.201489819 · Cited by 36
Hamann, L., Koch, A. H., Sur, S., Hoefer, N., Glaeser, C., Schulz, S., Gross, M. C., Franke, A., Nöthlings, U., Zacharowski, K. D., et al. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-43 · Cited by 37
Chen, S., Lee, Y., Crother, T. R., Fishbein, M. C., Zhang, W., Yılmaz, A., Shimada, K., Schulte, D. J., Lehman, T. J. A., Shah, P. K., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.249417 · Cited by 36
Self-citationHigh-Risk Cardiovascular Patients: Clinical Features, Comorbidities, and Interconnecting Mechanisms
Schuett, K. A., Lehrke, M., Marx, N., & Burgmaier, M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00591 · Cited by 36
Sun, J., Zhang, M., Chen, K., Chen, B., Zhao, Y., Gong, H., Zhao, X., & Qi, R. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.08.014 · Cited by 36
Habib, A., Polavarapu, R., Karmali, V., Guo, L., Dam, R. V., Cheng, Q., Akahori, H., Saeed, O., Nakano, M., Pachura, K. J., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.025 · Cited by 36
Kebir, D. E., József, L., & Filep, J. G. (2008) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-008-0008-3 · Cited by 36
Novel Protective Role of Myeloid Differentiation 1 in Pathological Cardiac Remodelling
Xiong, X., Liu, Y., Mei, Y., Peng, J., Wang, Z., Kong, B., Zhong, P., Xiong, L., Quan, D., Li, Q., et al. (2017) · Scientific Reports · doi:10.1038/srep41857 · Cited by 36
Gu, H., Li, N., Xu, Z., Hu, L., Li, H., Zhang, R.-J., Chen, R.-M., Zheng, X., Tang, Y., & Liao, D. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00165 · Cited by 36
IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis
Engelbertsen, D., Rattik, S., Wigren, M., Vallejo, J., Marinković, G., Șchiopu, A., Björkbacka, H., Nilsson, J. Å., & Bengtsson, E. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx196 · Cited by 35
Gut microbiome and cardiometabolic risk
Kappel, B. A., & Federici, M. (2019) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09533-9 · Cited by 36
Gu, H., Tang, C., Kuang, P., Sun, H., & Yang, Y.-Z. (2009) · BioMed Research International · doi:10.1155/2009/613879 · Cited by 35
Vaccines against atherosclerosis
Nilsson, J. Å., Wigren, M., & Shah, P. K. (2013) · Expert Review of Vaccines · doi:10.1586/erv.13.4 · Cited by 35
Self-citationVogel, S. N., Awomoyi, A. A., Rallabhandi, P., & Medvedev, A. E. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110060801 · Cited by 35
Inflammation and immunity in diabetic vascular complications
Nilsson, J. Å., Bengtsson, E., Fredrikson, G. N., & Björkbacka, H. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32830f47cd · Cited by 35
Role of Innate Immunity in Diabetes and Metabolism: Recent Progress in the Study of Inflammasomes
Lee, M. (2011) · Immune Network · doi:10.4110/in.2011.11.2.95 · Cited by 35
Klimentova, E. A., Suchkov, I. A., Egorov, A. A., & Kalinin, R. E. (2020) · Современные технологии в медицине · doi:10.17691/stm2020.12.4.13 · Cited by 34
Ji, Y., Liu, J., Wang, Z., & Li, Z. (2011) · Cytokine · doi:10.1016/j.cyto.2011.05.020 · Cited by 34
Jin, J., Samuvel, D. J., Zhang, X., Li, Y., Lu, Z., Lopes-Virella, M. F., & Huang, Y. Q. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.08.026 · Cited by 34
Zhang, R., Han, S., Zhang, Z., Zhang, W., Yang, J., Wan, Z., & Qin, L. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00380 · Cited by 34
Self-citationChen, T., Luo, W., Wu, G., Wu, L., Huang, S., Li, J., Wang, J., Hu, X., Huang, W., & Liang, G. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.03.012 · Cited by 35
Liu, T., Zheng, W., Wang, L., Wang, L., & Zhang, Y. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00078-5 · Cited by 34
Role of Toll-Like Receptor–Driven Innate Immunity in Thoracic Organ Transplantation
Goldstein, D. R., & Palmer, S. M. (2005) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2005.01.003 · Cited by 34
Liu, N., Liu, J., Ji, Y., Lu, P., Wang, C., & Guo, F. (2010) · Inflammation · doi:10.1007/s10753-010-9234-z · Cited by 34
Monaco, C. G., Terrando, N., & Midwood, K. S. (2010) · Arthritis Care & Research · doi:10.1002/acr.20382 · Cited by 36
Immunological perspectives on atherosclerotic plaque formation and progression
Pi, H., Wang, G., Wang, Y., Zhang, M., He, Q., Zheng, X., Yin, K., Zhao, G., & Jiang, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437821 · Cited by 35
Sun, A., Liu, H., Wang, S., Shi, D., Xu, L., Cheng, Y., Wang, K., Chen, K., Zou, Y., & Ge, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01518.x · Cited by 33
TRIF adaptor signaling is important in abdominal aortic aneurysm formation
Vorkapić, E., Lundberg, A. M., Mäyränpää, M. I., Eriksson, P. O., & Wågsäter, D. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.014 · Cited by 33
Lin, J., Liu, Q., Zhang, H., Huang, X., Zhang, R., Chen, S., Wang, X., Yu, B., & Hou, J. (2017) · Oncotarget · doi:10.18632/oncotarget.19657 · Cited by 33
CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis
Yu, L., Li, Y., Grisé, A., & Wang, H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6082-8_13 · Cited by 39
Najjar, R. S., Turner, C. G., Wong, B. J., & Feresin, R. G. (2021) · Nutrients · doi:10.3390/nu13020387 · Cited by 33
CITED2 inhibits STAT1‐IRF1 signaling and atherogenesis
Zafar, A., Ng, H. P., Diamond‐Zaluski, R., Kim, G., Chan, E. R., Dunwoodie, S. L., Smith, J. D., & Mahabeleshwar, G. H. (2021) · The FASEB Journal · doi:10.1096/fj.202100792r · Cited by 34
Bäckhed, F. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04123.x · Cited by 33
Reyna, S. M., Tantiwong, P., Cersósimo, E., DeFronzo, R. A., Sriwijitkamol, A., & Musi, N. (2013) · Journal of Diabetes Research · doi:10.1155/2013/107805 · Cited by 34
Toll-Like Receptors, Their Ligands, and Atherosclerosis
Hodgkinson, C. P., & Ye, S. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.36 · Cited by 33
Helper T cells and atherosclerosis: the cytokine web
Baidya, S. G., & Zeng, Q.-T. (2005) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.029827 · Cited by 33
AMPK integrates metabolite and kinase-based immunometabolic control in macrophages
Phair, I. R., Nisr, R. B., Howden, A. J. M., Sovakova, M., Alqurashi, N., Foretz, M., Lamont, D., Viollet, B., & Rena, G. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101661 · Cited by 32
Xu, X., Qi, X., Zhang, W., Zhang, C.-Q., Wu, X.-X., Wu, Y., Wang, K., & Shen, J. (2014) · Phytomedicine · doi:10.1016/j.phymed.2013.12.003 · Cited by 32
Self-citationIntertwining roles of circadian and metabolic regulation of the innate immune response
Cox, S. L., O’Siorain, J. R., Fagan, L. E., Curtis, A. M., & Carroll, R. G. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-021-00905-5 · Cited by 32
Li, X., Syrovets, T., Paskaš, S., Laumonnier, Y., & Simmet, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1215 · Cited by 32
Cyclooxygenase products and atherosclerosis
Linton, M. F., & Fazio, S. (2008) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2008.05.006 · Cited by 32
Oksaharju, A., Lappalainen, J., Tuomainen, A. M., Pussinen, P. J., Puolakkainen, M. H., Kovanen, P. T., & Lindstedt, K. A. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00285.x · Cited by 32
Lee, S.-H., Park, D., Park, S. C., Park, Y.-K., Hong, S. Y., Kim, J.-R., Lee, C., & Baek, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900503 · Cited by 33
Group X Secretory Phospholipase A2 Enhances TLR4 Signaling in Macrophages
Shridas, P., Bailey, W. M., Talbott, K. R., Oslund, R., Gelb, M. H., & Webb, N. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003552 · Cited by 33
Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis
Chen, S., Shimada, K., Crother, T. R., Erbay, E., Shah, P. K., & Arditi, M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.01.072 · Cited by 32
Self-citationInnate Immune Pathway Links Obesity to Insulin Resistance
Shah, P. K. (2007) · Circulation Research · doi:10.1161/circresaha.107.101104 · Cited by 31
Self-citationUnravelling monocyte functions: from the guardians of health to the regulators of disease
Mildner, A., Kim, K.-W., & Yona, S. (2024) · Discovery Immunology · doi:10.1093/discim/kyae014 · Cited by 35
Le, Y., Hu, X., Zhu, J., Wang, C., Yang, Z., & Lu, D. (2019) · Toxicology and Industrial Health · doi:10.1177/0748233719871778 · Cited by 31
Liu, Y., Yan, F., Liu, Y., Zhang, C., Yu, H., Zhang, Y., & Zhao, Y. (2008) · Phytotherapy Research · doi:10.1002/ptr.2429 · Cited by 31
Metadata
- Authors
- Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Corresponding author
- Arditi, Moshe
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-07-12
- Volume
- 101
- Issue
- 29
- Pages
- 10679-10684
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC489994
- OpenAlex
- W2018788678
- Cited by
- 1,019
- References
- 57
- Citations by year
- 2026: 20 · 2025: 17 · 2024: 25 · 2023: 25 · 2022: 35 · 2021: 21 · 2020: 36 · 2019: 52 · 2018: 36 · 2017: 37 · 2016: 43 · 2015: 64 · 2014: 53 · 2013: 68 · 2012: 68
- FWCI
- 18.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl058555-04)
- National Heart, Lung, and Blood Institute (HL66436, HL 58555, R01HL066436, R29HL051980, HL 51980, R01HL051980)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- TLR4, MyD88, atherosclerosis, apolipoprotein E deficiency, innate immunity, atherogenesis, aortic plaque, hypercholesterolemia, inflammatory cytokines, IL-12, MCP-1, macrophages, cyclooxygenase-2, plaque inflammation
- MeSH terms
- Animals, Antigens, Differentiation, Aorta, Apolipoproteins E, Arteriosclerosis, Cells, Cultured, Female, Humans, Immunity, Innate, Isoenzymes, Lipids, Macrophages, Male, Membrane Glycoproteins, Membrane Proteins, Mice, Inbred C57BL, Phenotype, Prostaglandin-Endoperoxide Synthases, Receptors, Cell Surface, Receptors, Immunologic, Signal Transduction, Mice, Knockout, Interleukin-12, Chemokine CCL2, Endothelial Cells, Adaptor Proteins, Signal Transducing, Lipid Metabolism, Toll-Like Receptors, Toll-Like Receptor 4, Mice, Cyclooxygenase 2, Myeloid Differentiation Factor 88
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review